Zum Hauptinhalt wechseln
https://catalogartifact.azureedge.net/publicartifacts/xenonstackprivatelimited1745486304915.elixirdata-pharma-ip-research-security-0a5a770b-8a4c-44cf-9679-ff4bef6358c4/image2_pharmaipresearchsecurity.png

Pharma IP & Research Security Intelligence

durch XenonStack

Protect pharma IP with unified threat intelligence across R&D, data access, and collaboration system

Overview

ElixirData (Context OS) delivers unified security intelligence for pharmaceutical R&D environments by protecting intellectual property and sensitive research data. It builds a semantic context graph across research systems, collaboration platforms, and enterprise IT to detect threats such as data exfiltration, unauthorized access, and anomalous behavior with full lineage and traceability.

Key Benefits

  • Unified threat intelligence across R&D, collaboration, and IT systems
  • Detection of data exfiltration, unauthorized access, and insider threats
  • Protection of clinical trial data and intellectual property
  • Correlation of user behavior, access patterns, and data movement signals
  • Root cause analysis with full context lineage and traceability
  • Compliance alignment with FDA 21 CFR Part 11 requirements

How It Works

ElixirData integrates with research platforms, document management systems, collaboration tools, identity systems, and data access logs to create a unified context graph.

It correlates signals such as unusual access to trial data, abnormal download patterns, collaboration anomalies, and system-level activity. This enables detection of sophisticated threats targeting pharmaceutical intellectual property.

Instead of isolated alerts, the platform provides reconciled intelligence enriched with full lineage — showing contributing signals, correlation paths, and reasoning behind each detected threat.

Business Impact

  • Reduced risk of intellectual property theft
  • Faster detection of insider threats and data exfiltration
  • Improved protection of clinical and research data
  • Enhanced compliance with regulatory requirements
  • Reduced false positives through contextual intelligence
  • Lower operational burden on security teams

Ideal For

  • Pharmaceutical companies managing R&D and clinical data environments
  • CISOs responsible for IP protection and cybersecurity
  • VP Research IT Security overseeing data access and compliance
  • Organizations handling sensitive trial data and proprietary research

Industries

  • Pharmaceuticals
  • Healthcare & Life Sciences
  • Biotechnology

Auf einen Blick

https://catalogartifact.azureedge.net/publicartifacts/xenonstackprivatelimited1745486304915.elixirdata-pharma-ip-research-security-0a5a770b-8a4c-44cf-9679-ff4bef6358c4/image0_elixirDmedical.png
https://catalogartifact.azureedge.net/publicartifacts/xenonstackprivatelimited1745486304915.elixirdata-pharma-ip-research-security-0a5a770b-8a4c-44cf-9679-ff4bef6358c4/image1_elixirDmedical1.png
https://catalogartifact.azureedge.net/publicartifacts/xenonstackprivatelimited1745486304915.elixirdata-pharma-ip-research-security-0a5a770b-8a4c-44cf-9679-ff4bef6358c4/image3_elixirDmedical2.png